Alcentra Capital (NASDAQ:ABDC) Downgraded to Hold at ValuEngine

ValuEngine downgraded shares of Alcentra Capital (NASDAQ:ABDC) from a buy rating to a hold rating in a report issued on Thursday, August 1st, ValuEngine reports.

NASDAQ ABDC traded down $0.01 during trading hours on Thursday, hitting $8.83. 42,588 shares of the company were exchanged, compared to its average volume of 109,275. The company has a 50 day moving average of $8.44 and a two-hundred day moving average of $8.06. Alcentra Capital has a 52-week low of $5.58 and a 52-week high of $9.40. The firm has a market cap of $113.82 million, a price-to-earnings ratio of 8.74 and a beta of 0.58.

Alcentra Capital (NASDAQ:ABDC) last released its quarterly earnings data on Wednesday, August 7th. The asset manager reported $0.20 EPS for the quarter, meeting analysts’ consensus estimates of $0.20. Alcentra Capital had a return on equity of 8.30% and a net margin of 31.91%. The business had revenue of $6.14 million for the quarter, compared to the consensus estimate of $6.11 million. Equities analysts expect that Alcentra Capital will post 0.8 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 3rd. Stockholders of record on Thursday, September 26th will be issued a $0.18 dividend. The ex-dividend date of this dividend is Wednesday, September 25th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 8.15%. Alcentra Capital’s payout ratio is currently 71.29%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Two Sigma Investments LP acquired a new stake in shares of Alcentra Capital during the fourth quarter worth about $265,000. Squarepoint Ops LLC acquired a new stake in shares of Alcentra Capital during the fourth quarter worth about $165,000. Millennium Management LLC acquired a new stake in shares of Alcentra Capital during the fourth quarter worth about $107,000. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Alcentra Capital during the first quarter worth about $85,000. Finally, Oppenheimer & Co. Inc. lifted its holdings in shares of Alcentra Capital by 226.1% during the first quarter. Oppenheimer & Co. Inc. now owns 33,257 shares of the asset manager’s stock worth $249,000 after purchasing an additional 23,059 shares during the period. Institutional investors and hedge funds own 35.57% of the company’s stock.

About Alcentra Capital

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

Featured Article: What is Considered a Good Return on Equity (ROE)?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.